ATE524561T1 - Verfahren zur bestimmung einer allergenreaktion unter verwendung von mikroarray-immunoassay- techniken - Google Patents

Verfahren zur bestimmung einer allergenreaktion unter verwendung von mikroarray-immunoassay- techniken

Info

Publication number
ATE524561T1
ATE524561T1 AT05733183T AT05733183T ATE524561T1 AT E524561 T1 ATE524561 T1 AT E524561T1 AT 05733183 T AT05733183 T AT 05733183T AT 05733183 T AT05733183 T AT 05733183T AT E524561 T1 ATE524561 T1 AT E524561T1
Authority
AT
Austria
Prior art keywords
immunoassay techniques
allergen response
microarray immunoassay
determining allergen
determining
Prior art date
Application number
AT05733183T
Other languages
English (en)
Inventor
Hugh Sampson
Wayne Shreffler
Kirsten Beyer
Original Assignee
Sinai School Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinai School Medicine filed Critical Sinai School Medicine
Application granted granted Critical
Publication of ATE524561T1 publication Critical patent/ATE524561T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT05733183T 2004-04-06 2005-03-22 Verfahren zur bestimmung einer allergenreaktion unter verwendung von mikroarray-immunoassay- techniken ATE524561T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55982504P 2004-04-06 2004-04-06
US62092304P 2004-10-21 2004-10-21
PCT/US2005/009567 WO2005100995A2 (en) 2004-04-06 2005-03-22 Methods of determining allergen response using microarray imminoassay techinques

Publications (1)

Publication Number Publication Date
ATE524561T1 true ATE524561T1 (de) 2011-09-15

Family

ID=35150593

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05733183T ATE524561T1 (de) 2004-04-06 2005-03-22 Verfahren zur bestimmung einer allergenreaktion unter verwendung von mikroarray-immunoassay- techniken

Country Status (4)

Country Link
US (2) US20090111702A1 (de)
EP (1) EP1733234B1 (de)
AT (1) ATE524561T1 (de)
WO (1) WO2005100995A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1873010B (zh) * 2006-04-14 2010-04-07 中国科学院武汉植物园 利用花生Ara h3启动子转基因载体的制备方法及应用
EP2003452A1 (de) * 2007-06-11 2008-12-17 Universität für Bodenkultur Wien Verfahren zur Diagnose einer Allergie
EP2694966A4 (de) * 2011-03-20 2014-12-24 Univ Colorado Regents Verfahren zur vorhersage der schwere einer allergischen reaktion
WO2013025519A1 (en) * 2011-08-12 2013-02-21 Rutgers, The State University Of New Jersey High throughput sensitization detection devices and methods
WO2014159609A1 (en) 2013-03-14 2014-10-02 Allergen Research Corporation Peanut formulations and uses thereof
EP4001920A1 (de) * 2014-04-03 2022-05-25 AllerGenis, LLC Peptide und verfahren für den nachweis von lebensmittelallergien
MA40824A (fr) 2014-10-22 2017-08-29 Saiba Gmbh Particules de cmv de type virus modifié
WO2017186808A1 (en) * 2016-04-27 2017-11-02 Allergy Therapeutics (Uk) Limited Treatment of peanut allergy
US11369676B2 (en) 2017-11-02 2022-06-28 Société des Produits Nestlé S.A. Methods of oral immunotherapy
WO2019226600A2 (en) * 2018-05-22 2019-11-28 AllerGenis LLC Peptides and methods for detecting peanut allergies
US12433945B2 (en) 2018-08-16 2025-10-07 Société des Produits Nestlé S.A. Peanut oral immunotherapy with maintenance dose
CA3123605A1 (en) 2018-12-20 2020-06-25 Aimmune Therapeutics, Inc. Peanut oral immunotherapy dosing schedule for missed doses
CA3137295A1 (en) 2019-05-10 2020-11-19 Aimmune Therapeutics, Inc. Methods for improving the quality of life of a patient with a peanut allergy
US20230003738A1 (en) * 2019-11-18 2023-01-05 Applied Medical Enzyme Research Institute Corporation Method for Collecting Data for Predicting Occurrence of Anaphylaxis
WO2021110896A1 (en) * 2019-12-04 2021-06-10 Astraveus Microfluidic device and method for processing particles
WO2021158857A1 (en) * 2020-02-06 2021-08-12 AllerGenis LLC Assays for detecting peanut allergies
TWI896841B (zh) * 2021-01-21 2025-09-11 日商東麗股份有限公司 過敏原固定化擔體及過敏原特異性抗體的檢測方法
JP7796376B2 (ja) * 2021-03-31 2026-01-09 学校法人藤田学園 牛乳アレルギーの新規抗原
WO2023200316A1 (ko) * 2022-04-15 2023-10-19 사회복지법인 삼성생명공익재단 경구면역요법을 이용한 식품알레르기 치료서비스 제공방법, 이를 구현하기 위한 기록매체에 저장된 컴퓨터 프로그램 및 시스템
CN115999664A (zh) * 2023-02-08 2023-04-25 南京仁迈生物科技有限公司 一种基于数字微流控芯片的全血分离血浆的方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US542225A (en) 1895-07-02 Machine for manufacture of paper boxes
US5422258A (en) * 1987-12-31 1995-06-06 Tanox Biosystems, Inc. Methods for producing high affinity anti-human IgE-monoclonal antibodies which binds to IgE on IgEabearing B cells but not basophils
US5449760A (en) 1987-12-31 1995-09-12 Tanox Biosystems, Inc. Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils
US5428133A (en) * 1987-12-31 1995-06-27 Tanox Biosystems, Inc. Chimeric anti-human IgE-monoclonal antibody which binds to secreted IgE and membrane-bound IgE expressed by IgE-expressing B cells but notto IgE bound to FC receptors on basophils
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
AT401180B (de) * 1990-08-13 1996-07-25 Biomay Biotech Prod Für das baumpollenallergen p14 codierende rekombinante dna-moleküle, daraus hergestellte und abgeleitete polypeptide und deren verwendung
US5605662A (en) * 1993-11-01 1997-02-25 Nanogen, Inc. Active programmable electronic devices for molecular biological analysis and diagnostics
US5558869A (en) * 1992-12-30 1996-09-24 University Of Arkansas Major peanut allergen ara h II
US6849427B1 (en) * 1993-03-12 2005-02-01 Immulogic Pharmaceutical Corp. Nucleic acids encoding a house dust mite allergen, Der p VII, and uses therefor
US5710126A (en) * 1993-03-12 1998-01-20 Immulogic Pharmaceutical Corporation T cell epitopes of ryegrass pollen allergen
US5449669A (en) * 1993-11-10 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services IgE-binding epitopes of a major heat-stable crustacean allergen derived from shrimp
US6287850B1 (en) * 1995-06-07 2001-09-11 Affymetrix, Inc. Bioarray chip reaction apparatus and its manufacture
SE9402089D0 (sv) * 1994-06-14 1994-06-14 Rudolf Valenta Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
CA2241918C (en) * 1995-12-29 2008-12-02 University Of Arkansas Peanut allergens and methods
US5801273A (en) * 1996-08-21 1998-09-01 Twenty-First Century Research Corporation Methods and devices for controlling the reaction rate of a hydrocarbon to an intermediate oxidation product by pressure drop adjustments
US6306170B2 (en) * 1997-04-25 2001-10-23 Tegementa, L.L.C. Threaded fusion cage anchoring device and method
US5994511A (en) 1997-07-02 1999-11-30 Genentech, Inc. Anti-IgE antibodies and methods of improving polypeptides
US6172213B1 (en) * 1997-07-02 2001-01-09 Genentech, Inc. Anti-IgE antibodies and method of improving polypeptides
US6504013B1 (en) * 2000-02-01 2003-01-07 Idexx Laboratories, Inc. Canine allergy therapeutic recombinant chimeric anti-IgE monoclonal antibody
ATE293159T1 (de) 1999-12-14 2005-04-15 Thermo Biostar Inc Stabilisierendes verdünnungsmittel für polypeptide und antigene
EP1195606A1 (de) * 2000-10-03 2002-04-10 VBC-Genomics Forschungsges.m.b.H. Allergen-Assay auf Basis von Mikroanordnungen
WO2002092125A1 (en) * 2001-05-11 2002-11-21 Novartis Ag Compositions for use in treating ige-associated disorders

Also Published As

Publication number Publication date
US20090111702A1 (en) 2009-04-30
EP1733234A2 (de) 2006-12-20
WO2005100995A2 (en) 2005-10-27
WO2005100995A3 (en) 2006-11-16
EP1733234B1 (de) 2011-09-14
US20150168389A1 (en) 2015-06-18
EP1733234A4 (de) 2008-05-07

Similar Documents

Publication Publication Date Title
WO2005100995A3 (en) Methods of determining allergen response using microarray imminoassay techinques
ATE511656T1 (de) Verfahren zur risikobewertung von herzeingriffen auf gdf-15-basis
ATE514950T1 (de) Verfahren zur untersuchung von sepsis bei menschen
ATE343591T1 (de) Antagonist für die multimerisierung von hiv-1 vif-protein
ATE333094T1 (de) Verfahren zur herstellung von protein-beladenen mikropartikeln
EP1971883A4 (de) Statistisches deterministisches verfahren zur vorhersage von naturkatastrophen
ATE493656T1 (de) Verfahren zur diagnose von multipler sklerose
ATE528648T1 (de) Verfahren zum nachweis antikörper-herstellender zellen
DE112005001710A5 (de) Verfahren zur Untersuchung des Verhaltens von komplexen Systemen, insbesondere von Brennkraftmaschinen
ATE550354T1 (de) Humane ringspezifische bnp-antikörper
ATE554616T1 (de) Verfahren zur verwendung in einem kommunikationssystem
ATE466283T1 (de) Zentrifugalvorrichtung und verfahren zur durchführung von bindungsversuchen
ATE473448T1 (de) Verfahren zur diagnose von herz-kreislauf- krankheiten
ATE376672T1 (de) Verfahren zur diagnose von multipler sklerose
ATE414701T1 (de) Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren
EP1784414A4 (de) Zusammensetzungen und verfahren zur bestimmung und vorhersage von behandlungsreaktionen bei depression und ängstlichkeit
ATE482398T1 (de) Verfahren zur stratifizierung von herzinsuffizienz
EP4397681A4 (de) Antikörper, immobilisierte antikörper damit, antikörperzusammensetzung, reagens für immunologische messung, immunologisches messverfahren und verfahren zur verbesserung der antigenantwort von antikörpern
DE602005007817D1 (de) Analyse-Verfahren unter Verwendung von abgeschwächter Totalreflektion
EP3622289C0 (de) Verfahren und testbesteck zur quantitativen bestimmung von biomarkern in fäkalproben
ATE437182T1 (de) Diagnose von allergischen erkrankungen, atopischen erkrankungen und/oder autoimmunerkrankungen durch nachweis von autoantikörpern gegen cd28 in humanem serum
DE602005015563D1 (de) Optisches verfahren zur bestimmung der verteilung von lipidpartikeln in einer probe
EP1861706A4 (de) Vorrichtungen und verfahren für analyttests mit eingebauter ergebnismitteilung unter verwendung erkennbarer symbole
ATE426807T1 (de) Proteomanalyse verfahren zum drogen vergleich
DE112005002199A5 (de) Verfahren und System zur Echtheitsbestimmung der individual-typischen Merkmale von Prüfobjekten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties